- Home
- Software Solutions
- Resources
- Corporate
Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer
Sponsors:
| Phases: | |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 30 | |
Additional information about NCT01378598.